Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $71,150 | 45 | 85.4% |
| Travel and Lodging | $4,829 | 39 | 5.8% |
| Consulting Fee | $4,044 | 2 | 4.9% |
| Food and Beverage | $3,247 | 151 | 3.9% |
| Education | $54.05 | 5 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $81,812 | 141 | $0 (2024) |
| GlaxoSmithKline, LLC. | $240.61 | 23 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $189.96 | 10 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $141.82 | 12 | $0 (2019) |
| Respiratory Technologies, Inc. | $83.38 | 3 | $0 (2017) |
| BOSTON SCIENTIFIC CORPORATION | $82.38 | 3 | $0 (2018) |
| United Therapeutics Corporation | $79.64 | 3 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $78.42 | 5 | $0 (2019) |
| Mallinckrodt LLC | $75.17 | 3 | $0 (2018) |
| ADVANCED RESPIRATORY, INC | $72.45 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $13,900 | 19 | AstraZeneca Pharmaceuticals LP ($13,900) |
| 2023 | $11,229 | 12 | AstraZeneca Pharmaceuticals LP ($11,229) |
| 2022 | $21,691 | 33 | AstraZeneca Pharmaceuticals LP ($21,691) |
| 2021 | $10,983 | 16 | AstraZeneca Pharmaceuticals LP ($10,964) |
| 2020 | $5,340 | 10 | AstraZeneca Pharmaceuticals LP ($5,340) |
| 2019 | $185.80 | 11 | AstraZeneca Pharmaceuticals LP ($46.34) |
| 2018 | $5,646 | 60 | AstraZeneca Pharmaceuticals LP ($5,005) |
| 2017 | $14,350 | 81 | AstraZeneca Pharmaceuticals LP ($13,637) |
All Payment Transactions
242 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug), AIRSUPRA | Education | In-kind items and services | $22.52 | General |
| Category: Respiratory | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,250.00 | General |
| Category: Respiratory | ||||||
| 10/02/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $950.00 | General |
| Category: Respiratory | ||||||
| 09/04/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $925.00 | General |
| Category: Respiratory | ||||||
| 08/28/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Travel and Lodging | In-kind items and services | $259.96 | General |
| Category: Respiratory | ||||||
| 07/01/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: Respiratory | ||||||
| 06/25/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $81.03 | General |
| Category: Respiratory | ||||||
| 06/25/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Travel and Lodging | In-kind items and services | $60.30 | General |
| Category: Respiratory | ||||||
| 06/12/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,350.00 | General |
| Category: Respiratory | ||||||
| 06/03/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Travel and Lodging | In-kind items and services | $41.54 | General |
| Category: Respiratory | ||||||
| 05/03/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,400.00 | General |
| Category: Respiratory | ||||||
| 04/10/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,400.00 | General |
| Category: Respiratory | ||||||
| 03/27/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: Respiratory | ||||||
| 03/27/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Travel and Lodging | In-kind items and services | $17.42 | General |
| Category: Respiratory | ||||||
| 03/27/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $0.65 | General |
| Category: Respiratory | ||||||
| 03/15/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Travel and Lodging | In-kind items and services | $29.48 | General |
| Category: Respiratory | ||||||
| 03/15/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: Respiratory | ||||||
| 03/12/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $150.00 | General |
| Category: Respiratory | ||||||
| 02/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $126.82 | General |
| Category: Respiratory | ||||||
| 12/12/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $300.00 | General |
| Category: Respiratory | ||||||
| 11/30/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,350.00 | General |
| Category: Respiratory | ||||||
| 11/16/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $950.00 | General |
| Category: Respiratory | ||||||
| 11/14/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Travel and Lodging | In-kind items and services | $36.68 | General |
| Category: Respiratory | ||||||
| 10/27/2023 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Education | In-kind items and services | $6.23 | General |
| Category: Respiratory | ||||||
| 09/13/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,700.00 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 256 | 447 | $48,001 | $17,640 |
| 2022 | 7 | 362 | 549 | $56,637 | $23,045 |
| 2021 | 7 | 328 | 509 | $50,025 | $21,321 |
| 2020 | 7 | 294 | 400 | $32,289 | $11,600 |
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 105 | 235 | $33,560 | $10,647 | 31.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 29 | 56 | $6,559 | $3,347 | 51.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 16 | 24 | $4,104 | $2,030 | 49.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 15 | 25 | $1,614 | $949.25 | 58.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 38 | 52 | $1,092 | $323.52 | 29.6% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 26 | 27 | $540.00 | $175.50 | 32.5% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 27 | 28 | $532.00 | $167.94 | 31.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 125 | 229 | $27,900 | $10,668 | 38.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 26 | 52 | $8,606 | $4,020 | 46.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 30 | 61 | $7,004 | $3,201 | 45.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 20 | 20 | $6,680 | $2,689 | 40.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 11 | 11 | $1,929 | $850.67 | 44.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 99 | 117 | $2,340 | $733.03 | 31.3% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 15 | 23 | $1,458 | $666.52 | 45.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2022 | 36 | 36 | $720.00 | $216.75 | 30.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 101 | 198 | $22,968 | $9,849 | 42.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 25 | 61 | $10,004 | $4,879 | 48.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 25 | 25 | $8,275 | $3,289 | 39.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 17 | 22 | $2,486 | $1,225 | 49.3% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 105 | 128 | $2,560 | $795.34 | 31.1% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Facility | 2021 | 18 | 30 | $1,950 | $644.04 | 33.0% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Facility | 2021 | 11 | 18 | $1,242 | $477.70 | 38.5% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Office | 2021 | 26 | 27 | $540.00 | $162.50 | 30.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 74 | 105 | $12,148 | $2,994 | 24.6% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 12 | 17 | $8,534 | $2,966 | 34.8% |
About Dr. James Pearl, MD
Dr. James Pearl, MD is a Critical Care Medicine healthcare provider based in Salt Lake City, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/11/2005. The National Provider Identifier (NPI) number assigned to this provider is 1417959206.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Pearl, MD has received a total of $83,324 in payments from pharmaceutical and medical device companies, with $13,900 received in 2024. These payments were reported across 242 transactions from 24 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($71,150).
As a Medicare-enrolled provider, Pearl has provided services to 1,240 Medicare beneficiaries, totaling 1,905 services with total Medicare billing of $73,606. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease
- Location Salt Lake City, UT
- Active Since 08/11/2005
- Last Updated 09/15/2021
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1417959206
Products in Payments
- BREZTRI (Drug) $57,620
- BEVESPI AEROSPHERE (Drug) $13,536
- BREZTRI AEROSPHERE (Drug) $5,340
- FASENRA (Drug) $4,952
- SYMBICORT (Drug) $168.32
- AIRSUPRA (Drug) $152.14
- NUCALA (Biological) $94.48
- ZERBAXA (Drug) $78.42
- ACTHAR (Biological) $75.17
- OFEV (Drug) $73.92
- The Vest System Model 105 Home Care (Device) $72.45
- BROVANA (Drug) $61.80
- AVYCAZ (Drug) $58.31
- STIOLTO RESPIMAT (Drug) $58.29
- BREO (Drug) $54.76
- GENERAL PULMONARY (Device) $53.18
- Perforomist (Drug) $47.19
- ORENITRAM (Drug) $46.80
- BEVYXXA (Drug) $46.31
- TRELEGY ELLIPTA (Drug) $40.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Salt Lake City
Robert Mazzola, Md, MD
Critical Care Medicine — Payments: $11,895
Kurt Francis, Md, MD
Critical Care Medicine — Payments: $7,645
Dr. Ann Jefferds, Md, MD
Critical Care Medicine — Payments: $7,205
Michael Bourne, Md, MD
Critical Care Medicine — Payments: $5,632
Jamis Gouge, Md, MD
Critical Care Medicine — Payments: $1,344
Dr. Cheryl Pirozzi, M.d, M.D
Critical Care Medicine — Payments: $1,014